Clinical Trial Update: A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus [Phase 3]

View source ↗

Summary

Phase 3 trial of ABCD for Injection for invasive candidiasis and invasive aspergillosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Candidiasis

Drugs mentioned

• ABCD for Injection

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Invasive Candidiasis, Invasive Aspergillosis | Phase 3 | Status: COMPLETED